Pelareorep + FOLFIRINOX ± Atezolizumab Safe in Metastatic PDAC: GOBLET Study
The Promising Potential of Combining Pelareorep with mFOLFIRINOX In the ever-evolving landscape of cancer treatment, groundbreaking research often heralds new hope. A striking example is the recent findings from the safety run-in portion of the GOBLET study, presented at the 2025 Gastrointestinal Cancers Symposium. This study explores the combination of pelareorep with mFOLFIRINOX, with or … Read more